Choudhury Arnab, Bairwa Mukesh, Jithesh G, Kumar Sahil, Kumar Nitin
Department of Medicine, Military Hospital, Ambala, India.
Department of Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Indian J Crit Care Med. 2024 Jul;28(7):686-695. doi: 10.5005/jp-journals-10071-24746.
Nontraumatic brain injury encompasses various pathological processes and medical conditions that result in brain dysfunction and neurological impairment without direct physical trauma. The study aimed to assess the efficacy of intravenous administration of 20% mannitol and 3% hypertonic saline to reduce intracranial pressure in nontraumatic brain injury.
The Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were followed for study selection and data extraction. The search was conducted in the PubMed, Embase, and Scopus databases, including articles published in English from January 2003 to December 2023. Our study included randomized controlled trials, comparative studies, prospective analyses, and retrospective cohort studies. We extracted data on baseline characteristics of patients, intervention details, major outcomes, and complications. Quality assessment was performed using the Jadad scale and the Robvis assessment tool for risk of bias.
A total of 14 studies involving 1,536 patients were included in the analysis. Seven studies reported hypertonic saline as more effective in reducing intracranial pressure, while three studies found similar effectiveness for both interventions. Adverse events were reported in only three studies. The studies that reported complication rates ranged from 21 to 79%. A meta-analysis was conducted on five studies, showing varying rates of adverse events associated with mannitol and hypertonic saline.
Both hypertonic saline solution and mannitol have been explored as treatment options for decreasing intracranial pressure in nontraumatic brain injuries. While some studies indicate the superiority of hypertonic saline, others report similar effectiveness between the two interventions.
Choudhury A, Ravikant, Bairwa M, Jithesh G, Kumar S, Kumar N. Efficacy of Intravenous 20% Mannitol vs 3% Hypertonic Saline in Reducing Intracranial Pressure in Nontraumatic Brain Injury: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2024;28(7):686-695.
非创伤性脑损伤涵盖各种病理过程和病症,这些病理过程和病症会导致脑功能障碍和神经功能损害,且无直接身体创伤。本研究旨在评估静脉输注20%甘露醇和3%高渗盐水降低非创伤性脑损伤颅内压的疗效。
遵循系统评价和Meta分析的首选报告项目指南进行研究选择和数据提取。检索了PubMed、Embase和Scopus数据库,包括2003年1月至2023年12月发表的英文文章。我们的研究包括随机对照试验、比较研究、前瞻性分析和回顾性队列研究。我们提取了患者的基线特征、干预细节、主要结局和并发症的数据。使用Jadad量表和Robvis偏倚风险评估工具进行质量评估。
分析共纳入14项研究,涉及1536例患者。7项研究报告高渗盐水在降低颅内压方面更有效,而3项研究发现两种干预措施效果相似仅3项研究报告了不良事件。报告并发症发生率的研究范围为21%至79%。对5项研究进行了Meta分析,显示甘露醇和高渗盐水相关不良事件发生率各不相同。
高渗盐溶液和甘露醇均已被探索作为降低非创伤性脑损伤颅内压的治疗选择。虽然一些研究表明高渗盐水更具优势,但其他研究报告两种干预措施效果相似。
乔杜里A,拉维坎特,拜尔瓦M,吉特什G,库马尔S库马尔N。静脉输注20%甘露醇与3%高渗盐水降低非创伤性脑损伤颅内压的疗效:一项系统评价和Meta分析。《印度危重症医学杂志》2024;28(7):686-695。